Afternoon review of Hong Kong stock market

Topic 558 news 13301 Subscribers

Hong Kong stocks see a slight decline in the three major stock indices in the afternoon, with the technology index rising more than 1%; photovoltaic and biotechnology stocks leading the gains all day, flat glass soaring more than 23%, wuxi apptec rising m

Futu News · Oct 25 16:30

富途资讯10月25日消息，三大指数午后小幅回落，恒指涨0.49%，国指涨0.35%，科指收涨逾1%。

截至收盘，港股上涨1143只，下跌820只，收平1109只。

具体行业表现如下图：

板块方面，科网股普涨，小米集团-W涨2.77%，快手-W涨1.44%，京东集团-SW涨1.30%，阿里巴巴-W涨1.27%，美团-W跌1.12%，网易-S涨0.81%，商汤-W涨0.63%，腾讯控股跌0.24%。

光伏太阳能股上扬，福莱特玻璃涨23.04%，协鑫科技涨19.58%，信义光能涨16.99%，新特能源涨11.83%，信义能源涨11.63%，凯盛新能涨6.68%，信义玻璃涨5.85%，福耀玻璃跌0.09%。

生物技术股纷纷上行，宜明昂科-B涨24.36%，再鼎医药涨15.02%，泰格医药涨13.14%，药明康德涨7.11%，药明生物涨5.95%，康方生物涨2.66%，云顶新耀-B涨2.24%，百济神州跌0.62%。

汽车股上扬，吉利汽车涨8.20%，理想汽车-W涨5.10%，长城汽车涨4.66%，零跑汽车涨3.12%，比亚迪股份涨2.38%，小鹏汽车-W跌1.88%，华晨中国跌1.53%，蔚来-SW跌0.76%。

锂电池股表现亮眼，洪桥集团涨11.25%，赣锋锂业涨8.78%，中创新航涨8.07%，天齐锂业涨7.00%，比亚迪电子涨4.10%，天能动力涨2.90%，比亚迪股份涨2.38%，理士国际收平。

互联网医疗股走高，麦迪卫康涨5.41%，京东健康涨5.07%，众安在线涨3.55%，阿里健康涨2.61%，平安好医生涨0.51%，叮当健康收平。

个股方面， $贝壳-W (02423.HK)$涨近4%，新房、二手房销售明显回暖，机构看好公司盈利上行潜力。

$小米集团-W (01810.HK)$ 涨近3%，小米SU7 Ultra量产版开启预约咨询通道，原型车纽北刷圈正等待新窗口期。

$比亚迪股份 (01211.HK)$ 涨超2%，9月10-15万元汽车销量Top20出炉，比亚迪占据“半壁江山”。

$福莱特玻璃 (06865.HK)$ 涨超23%，中银国际称光伏供给侧改革持续推进，产业链利润或修复。

$长城汽车 (02333.HK)$涨近5%，今日将发三季度业绩，新能源销量同环比提升。

$宜明昂科-B (01541.HK)$涨超24%，香港审批机制11月起扩展至所有新药。

$天齐锂业 (09696.HK)$ 涨7%，大摩称天齐锂业第三季亏损3.2亿至6.4亿元大致符合预，维持“增持”评级。

今日成交额TOP10

港股通资金

港股通方面，今日港股通（南向）净流入92.01亿港元。

机构观点：

花旗：预期美团第三季业绩表现将稳健，维持“买入”评级。

花旗发表研究报告指， $美团-W (03690.HK)$ 将于下月底公布第三季业绩，预期受惠于到店消费、旅行需求以及即时购物的增长，季绩表现将稳健，同时在严格的成本控制和经营杠杆改善推动下，每名用户经济效益及利润率可能会超出预期，维持“买入”评级及目标价192港元不变。

招银国际：上调中国平安目标价至65.1港元，维持“买入”评级。

招银国际发表报告，指 $中国平安 (02318.HK)$ 在2024年第三季度录得强劲的业绩，集团净利润以及寿险和健康保险新业务价值均实现翻倍增长。进入2024年第四季度，随着业务愈加明朗，该行预计中国平安在2024财年新业价值将增长超过20%，并有可能在2025年第一季度保持这一增长势头。该行将中国平安H股目标价由52港元上调至65.1港元，维持“买入”评级。

大摩：滔搏上半财年业绩符预期，予目标价3.7港元。

摩根士丹利发表报告，指 $滔搏 (06110.HK)$ 8月底止上半财年业绩符预期，盈利倒退与早前盈警一致，市场对其预测经已大幅削减。由于现有库存有待清理及经营环境具挑战性，该行料滔搏管理层就明年2月底止下半财年维持保守口径，予“增持”评级，目标价3.7港元。

编辑/Wade

futu news on October 25, the three major indices slightly retreated in the afternoon, with a 0.49% rise in the Hang Seng Index, a 0.35% rise in the national index, and a over 1% increase in the technology index.

As of the close, 1143 stocks rose in the Hong Kong stock market, 820 fell, and 1109 remained unchanged.

The specific industry performance is shown in the following figure:

Sector-wise, technology stocks generally rose, with Xiaomi Group-W up by 2.77%, Kuaishou-W up by 1.44%, JD.com-SW up by 1.30%, Alibaba-W up by 1.27%, Meituan-W down by 1.12%, Netease-S up by 0.81%, Sensetime-W up by 0.63%, and Tencent down by 0.24%.

Photovoltaic solar energy stocks rose, with Flat Glass up by 23.04%, GCL Tech up by 19.58%, Xinyi Solar up by 16.99%, Xinte Energy up by 11.83%, Xinyi Energy up by 11.63%, Triumph New En up by 6.68%, Xinyi Glass up by 5.85%, and Fuyao Glass down by 0.09%.

Biotechnology stocks surged, with Amgen-B up by 24.36%, Zai Lab up by 15.02%, Tigermed up by 13.14%, Wuxi Apptec up by 7.11%, Wuxi Bio up by 5.95%, Akeso up by 2.66%, Ucloudlink-B up by 2.24%, and Beigene down by 0.62%.

Automobile stocks rose, with Geely Auto up by 8.20%, Li Auto Inc-W up by 5.10%, Great Wall Motor up by 4.66%, Leapmotor up by 3.12%, BYD Company Limited up by 2.38%, Xpeng-W down by 1.88%, Brilliance Chi down by 1.53%, and Nio Inc-SW down by 0.76%.

Lithium battery stocks performed well, with Honbridge up by 11.25%, Ganfeng Lithium up by 8.78%, GCL Tech up by 8.07%, Tianqi Lithium Corporation up by 7.00%, BYD Electronic up by 4.10%, Tianneng Power up by 2.90%, BYD Company up by 2.38%, and Leoch Int'l remaining unchanged.

Digital health stocks rose, Maidiweikang increased by 5.41%, JD Health by 5.07%, za online by 3.55%, Ali Health by 2.61%, Ping An Good Doctor by 0.51%, and Dingdang Health remained flat.

As for individual stocks,$BEKE-W (02423.HK)$Rising nearly 4%, new and second-hand home sales have significantly rebounded, with institutions optimistic about the company's profit growth potential.

$XIAOMI-W (01810.HK)$ Rising nearly 3%, Xiaomi's SU7 Ultra mass-produced version has opened the reservation consultation channel, and the test prototype is waiting for a new window to circle the Arctic Circle.

$BYD COMPANY (01211.HK)$ Rising over 2%, the Top 20 car sales in September totaled 0.1-0.15 million yuan, with BYD occupying a dominant position.

$FLAT GLASS (06865.HK)$ Rising more than 23%, BOC International stated that the photovoltaic supply side reform continues to advance, and industry chain profits may recover.

$GWMOTOR (02333.HK)$Increasing by nearly 5%, today will release third-quarter performance, with new energy sales volume increasing monthly and quarterly.

$IMMUNEONCO-B (01541.HK)$Rising over 24%, Hong Kong's approval mechanism will be expanded to all new drugs from November.

$TIANQI LITHIUM (09696.HK)$ Up by 7%, Morgan Stanley stated that the third quarter loss of Tianqi Lithium Corporation ranging from 0.32 billion to 0.64 billion yuan is roughly in line with expectations, maintaining a 'shareholding' rating.

TOP 10 trading volume today

Hong Kong Stock Connect Fund

In terms of the Hong Kong Stock Connect, the net inflow of Hong Kong Stock Connect (Southbound) today was 9.201 billion Hong Kong dollars.

Institutional perspective:

Citi: It is expected that Meituan's performance in the third quarter will be stable, maintaining a 'buy' rating.

Citigroup released a research report stating, $MEITUAN-W (03690.HK)$ Will announce third-quarter performance at the end of next month, expected to benefit from growth in offline consumption, travel demand, and instant shopping. The quarterly performance is expected to be stable, while strict cost control and improvement in operating leverage may lead to better-than-expected economic benefits and profit margins per user, maintaining a 'buy' rating and an unchanged target price of 192 Hong Kong dollars.

CICC Securities: Raises the target price of Ping An Insurance in China to HK$65.1, maintains a 'buy' rating.

CICC Securities released a report, indicating $PING AN (02318.HK)$ that in the third quarter of 2024, strong performance was recorded, with the group's net income and the new business value of life and health insurance both achieving double-digit growth. In the fourth quarter of 2024, as the business becomes clearer, the bank expects Ping An Insurance in China to increase its new business value by over 20% in the 2024 fiscal year, and possibly maintain this growth momentum in the first quarter of 2025. The bank raised the target price of Ping An Insurance in China's H shares from HK$52 to HK$65.1, maintaining a 'buy' rating.

Morgan Stanley: TAL Education's first half-year performance in line with expectations, with a target price of HK$3.7.

Morgan Stanley released a report, indicating $TOPSPORTS (06110.HK)$ that at the end of August, TAL Education's first half-year performance met expectations, with profits declining in line with previous profit warnings, leading to a significant reduction in market forecasts. Due to the need to clear existing inventory and challenging operating conditions, the bank expects TAL Education's management to maintain a conservative stance for the second half of next fiscal year until the end of February, giving it a 'hold' rating with a target price of HK$3.7.

编辑/Wade

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.